Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study

Dirk De Ruysscher*, Anne-Marie C. Dingemans, John Praag, Jose Belderbos, Caroline Tissing-Tan, Judith Herder, Tjeerd Haitjema, Fred Ubbels, Frank Lagerwaard, Sherif Y. El Sharouni, Jos A. Stigt, Egbert Smit, Harm van Tinteren, Vincent van der Noort, Harry J. M. Groen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2366-2377
Number of pages12
JournalJournal of Clinical Oncology
Volume36
Issue number23
DOIs
Publication statusPublished - 10 Aug 2018

Keywords

  • BRAIN METASTASES
  • COMPLETE REMISSION
  • RADIATION-THERAPY
  • HIGH-RISK
  • TRIAL
  • CHEMORADIOTHERAPY
  • CHEMOTHERAPY
  • SURVIVAL

Cite this

De Ruysscher, D., Dingemans, A-M. C., Praag, J., Belderbos, J., Tissing-Tan, C., Herder, J., Haitjema, T., Ubbels, F., Lagerwaard, F., El Sharouni, S. Y., Stigt, J. A., Smit, E., van Tinteren, H., van der Noort, V., & Groen, H. J. M. (2018). Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study. Journal of Clinical Oncology, 36(23), 2366-2377. https://doi.org/10.1200/JCO.2017.77.5817